Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration

NCT01678872 is registered in ClinicalTrials.gov with Oxford BioMedica as lead sponsor.

NCT NCT01678872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01678872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long Term Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
Lead sponsor
Oxford BioMedica
Phase
Phase 1
Overall status
Active, not recruiting
Start date
August 31, 2012
Completion date
March 31, 2029
Enrollment
18 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration